Does prasugrel achieve superior platelet inhibition when compared with clopidogrel in patients with CAD?

被引：0
|
作者：
Meinrad Gawaz
机构：
[1] Eberhard-Karls University of Tübingen,professor and Director of the Department of Medicine
来源：
Nature Clinical Practice Cardiovascular Medicine | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：648 / 649
页数：1
相关论文
共 50 条
  • [41] Switching Elderly Patients With High On-treatment Platelet Reactivity From Clopidogrel to Prasugrel
    Lhermusier, Thibault
    Mejean, Simon
    Voisin, Sophie
    Bataille, Vincent
    Chollet, Thomas
    Sayir, Sylvain
    Sie, Pierre
    Carrie, Didier
    CIRCULATION, 2014, 130
  • [42] THE ANTI-PLATELET EFFECT OF PRASUGREL AS COMPARED WITH CLOPIDOGREL IN ST-ELEVATION ACUTE MYOCARDIAL INFARCTION PATIENTS UNDERGOING PRIMARY ANGIOPLASTY
    Beigel, Roy
    Herscovici, Romana
    Fefer, Paul
    Hod, Hanoch
    Matetzky, Shlomi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (13) : E480 - E480
  • [43] Platelet inhibition with prasugrel (CS-747) versus clopidogrel in patients undergoing coronary stenting: The subset from the JUMBO trial
    Serebruany, Victor L.
    Midei, Mark
    Meilman, Henry
    Malinin, Alex
    Lowry, David
    CIRCULATION, 2006, 114 (18) : 813 - 814
  • [44] Prasugrel (CS-747) achieves significantly higher inhibition of platelet aggregation and a lower rate of nonresponders compared with clopidogrel in aspirin-treated patients with atherosclerotic vascular disease
    Winters, KJ
    Jernberg, T
    Leese, PT
    Nilsson, LG
    Payne, CD
    Darstein, C
    Brandt, JT
    Jakubowski, JA
    Siegbahn, A
    Wallentin, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (7A): : 154H - 154H
  • [45] Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial
    Michelson, Alan D.
    Frelinger, Andrew L., III
    Braunwald, Eugene
    Downey, William E.
    Angiolillo, Dominick J.
    Xenopoulos, Nicholas P.
    Jakubowski, Joseph A.
    Li, Youfu
    Murphy, Sabina A.
    Qin, Jie
    McCabe, Carolyn H.
    Antman, Elliott M.
    Wiviott, Stephen D.
    EUROPEAN HEART JOURNAL, 2009, 30 (14) : 1753 - 1763
  • [46] Switching patients from clopidogrel to prasugrel in acute coronary syndrome: effects of prasugrel loading dose on residual platelet reactivity
    Lhermusier, T.
    Voisin, S.
    Mejean, S.
    Garcia, C.
    Sie, P.
    Carrie, D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (09) : 1946 - 1949
  • [47] Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Patients With Acute Coronary Syndromes Results of the SWAP (SWitching Anti Platelet) Study
    Angiolillo, Dominick J.
    Saucedo, Jorge F.
    DeRaad, Roger
    Frelinger, Andrew L.
    Gurbel, Paul A.
    Costigan, Timothy M.
    Jakubowski, Joseph A.
    Ojeh, Clement K.
    Effron, Mark B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : 1017 - 1023
  • [48] What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel
    Testa, L.
    Bhindi, R.
    Van Gaal, W. J.
    Latini, R. A.
    Pizzocri, S.
    Lanotte, S.
    Zoccai, G. G. L. Biondi
    Valgimigli, M.
    Laudisa, M. L.
    Brambilla, N.
    Banning, A. P.
    Bedogni, F.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2010, 103 (06) : 367 - 377
  • [49] Therapy with ticagrelor/prasugrel is associated with enhanced fibrinolysis and suppressed platelet activation as compared to clopidogrel in chronic coronary syndrome
    Paszek, Elzbieta
    Natorska, Joanna
    Zabczyk, Michal
    Klajmon, Adrianna
    Undas, Anetta
    KARDIOLOGIA POLSKA, 2023, 81 (11) : 1130 - 1133
  • [50] Effects of rosuvastatin on platelet inhibition by clopidogrel in cardiovascular patients
    Silvia Riondino
    Natalia Petrini
    Luciamaria Donato
    Concetta Torromeo
    Gaetano Tanzilli
    Fabio M. Pulcinelli
    Francesco Barillà
    Journal of Thrombosis and Thrombolysis, 2009, 28 : 151 - 155
12345